These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 12826473)

  • 1. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity.
    Welshons WV; Thayer KA; Judy BM; Taylor JA; Curran EM; vom Saal FS
    Environ Health Perspect; 2003 Jun; 111(8):994-1006. PubMed ID: 12826473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic endocrine-disrupting chemicals: molecular mechanisms of actions on putative human diseases.
    Yoon K; Kwack SJ; Kim HS; Lee BM
    J Toxicol Environ Health B Crit Rev; 2014; 17(3):127-74. PubMed ID: 24749480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is exposure to environmental or industrial endocrine disrupting estrogen-like chemicals able to cause genomic instability?
    Roy D; Colerangle JB; Singh KP
    Front Biosci; 1998 Aug; 3():d913-21. PubMed ID: 9696883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health risk assessment of endocrine disrupting chemicals].
    Tohyama C; Ohsako S; Ishimura R
    Nihon Rinsho; 2000 Dec; 58(12):2393-400. PubMed ID: 11187727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental signaling: from environmental estrogens to endocrine-disrupting chemicals and beyond.
    McLachlan JA
    Andrology; 2016 Jul; 4(4):684-94. PubMed ID: 27230799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta.
    Fujimoto N; Kitamura S
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):53-9. PubMed ID: 15026083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine disruptors: can biological effects and environmental risks be predicted?
    Witorsch RJ
    Regul Toxicol Pharmacol; 2002 Aug; 36(1):118-30. PubMed ID: 12383724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental estrogenic effects of alkylphenol ethoxylates.
    Nimrod AC; Benson WH
    Crit Rev Toxicol; 1996 May; 26(3):335-64. PubMed ID: 8726166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review.
    Melnick R; Lucier G; Wolfe M; Hall R; Stancel G; Prins G; Gallo M; Reuhl K; Ho SM; Brown T; Moore J; Leakey J; Haseman J; Kohn M
    Environ Health Perspect; 2002 Apr; 110(4):427-31. PubMed ID: 11940462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review of methods for comparing estrogenic activity of endogenous and exogenous chemicals in human milk and infant formula.
    Borgert CJ; LaKind JS; Witorsch RJ
    Environ Health Perspect; 2003 Jun; 111(8):1020-36. PubMed ID: 12826475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vivo test for endocrine disruptors].
    Kanno J
    Nihon Rinsho; 2000 Dec; 58(12):2495-501. PubMed ID: 11187744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice.
    Welshons WV; Nagel SC; Thayer KA; Judy BM; Vom Saal FS
    Toxicol Ind Health; 1999; 15(1-2):12-25. PubMed ID: 10188188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation and implementation of the ERE-CALUX bioassay on indoor dust samples of kindergartens to assess estrogenic potencies.
    Vandermarken T; De Galan S; Croes K; Van Langenhove K; Vercammen J; Sanctorum H; Denison MS; Goeyens L; Elskens M; Baeyens W
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):182-9. PubMed ID: 25595043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: neurobiological impact of environmental estrogens.
    Panzica GC; Viglietti-Panzica C; Ottinger MA
    Brain Res Bull; 2005 Apr; 65(3):187-91. PubMed ID: 15811580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.
    Mattison DR; Karyakina N; Goodman M; LaKind JS
    Crit Rev Toxicol; 2014 Sep; 44(8):696-724. PubMed ID: 25099693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
    Dogan S; Simsek T
    Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ignoring estrogenic mixtures underestimates risk.
    Erickson BE
    Environ Sci Technol; 2002 May; 36(9):179A-180A. PubMed ID: 12026960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.